|Traded as||MCX: PHST
|Key people||Viktor Vladimirovich Kharitonin,(Chairman)
Igor Konstantinovich Krylov, (CEO)
|Revenue||US$ 1.6 billion (2012)|
|Profit||US$ 321.1 million (2012)|
Pharmstandard is the leading Russian pharmaceutical company, its headquartered in Dolgoprudny.
Pharmstandard portfolio includes over 200 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc. Over 90 products offered by Pharmstandard are included in the List of Vital Pharmaceutical Products.